glp-1 and gip receptor agonist Agonists – Peripheral Brain Beyond the pancreas: contrasting cardiometabolic
Description
Shortages and expiry date of medicines and stringent regulatory requirements are key limiting factors driving the market
BL, baseline
As per the data from the University of California Health Data Warehouse, Ozempic (semaglutide, a GLP-1 RA) users have increased from 569 to 7667 to 22,891 in 2019, 2020, and 2022, respectively [5]
Wegovy may cause gallbladder problems, including gallstones
Ozempic is an FDA-approved prescription medication for the treatment of type 2 diabetes alongside diet and exercise
DOI: 10.1016/j.jacc.2021.10.041
